345 related articles for article (PubMed ID: 36685527)
1. Postpartum hepatitis and host immunity in pregnant women with chronic HBV infection.
Zhang L; Jiang T; Yang Y; Deng W; Lu H; Wang S; Liu R; Chang M; Wu S; Gao Y; Hao H; Shen G; Xu M; Chen X; Hu L; Yang L; Bi X; Lin Y; Lu Y; Jiang Y; Li M; Xie Y
Front Immunol; 2022; 13():1112234. PubMed ID: 36685527
[TBL] [Abstract][Full Text] [Related]
2. Effects of hepatitis B virus infection and strategies for preventing mother-to-child transmission on maternal and fetal T-cell immunity.
Lu H; Cao W; Zhang L; Yang L; Bi X; Lin Y; Deng W; Jiang T; Sun F; Zeng Z; Lu Y; Zhang L; Liu R; Gao Y; Wu S; Hao H; Chen X; Hu L; Xu M; Xiong Q; Dong J; Song R; Li M; Xie Y
Front Immunol; 2023; 14():1122048. PubMed ID: 36875136
[TBL] [Abstract][Full Text] [Related]
3. Total Alanine Aminotransferase (ALT) Flares in Pregnant North American Women With Chronic Hepatitis B Infection: Results From a Prospective Observational Study.
Bzowej NH; Tran TT; Li R; Belle SH; Smith CI; Khalili M; Chung R; Tsai N; Terrault N;
Am J Gastroenterol; 2019 Aug; 114(8):1283-1291. PubMed ID: 31082876
[TBL] [Abstract][Full Text] [Related]
4. Effect of prophylactic antiviral intervention on T cell immunity in hepatitis B virus-infected pregnant women.
Huang M; Gao Y; Liao D; Ma Y; Li J; Tang B; Hao Y; Zhang X; Yin S; Jiang X; Li J; Yin X; Li Y; Hu J; Liu Z
BMC Pregnancy Childbirth; 2023 May; 23(1):392. PubMed ID: 37245038
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Therapy for Prevention of Perinatal Hepatitis B Virus Transmission Reduces the Incidence of Postpartum Hepatitis Flare.
Quan M; Liu XM; Liu C; Li W; Xing HC
Biomed Res Int; 2022; 2022():7046955. PubMed ID: 35860799
[No Abstract] [Full Text] [Related]
6. [Clinical study on blocking mother-to-child transmission of hepatitis B virus with high viral load and HBeAg positivity during pregnancy in Guizhou province].
Zhang BF; Cheng ML; Zhang Q; Zhao XK; Yu L; Yang J; Deng KS; Zhang LS; Wang J; Hu YX
Zhonghua Gan Zang Bing Za Zhi; 2018 Dec; 26(12):945-950. PubMed ID: 30669789
[No Abstract] [Full Text] [Related]
7. Clinical Features and T Cell Immune Characteristics of Postpartum Hepatitis Flare in Pregnant Women With HBeAg-Positive Chronic HBV Infection.
Song A; Liu Y; Cao Z; Lu J; Ren S; Zheng S; Ma L; Hu Z; Lin X; Li H; Zheng Y; Chen X
Front Immunol; 2022; 13():881321. PubMed ID: 35493501
[TBL] [Abstract][Full Text] [Related]
8. [A real-world study on the features of postpartum hepatitis flares in pregnant women with chronic HBV infection].
Zeng Z; Zhou MF; Lin YJ; Bi XY; Yang L; Deng W; Jiang TT; Hu LP; Xu MJ; Zhang L; Yi W; Li MH
Zhonghua Gan Zang Bing Za Zhi; 2024 Feb; 32(2):113-118. PubMed ID: 38514259
[No Abstract] [Full Text] [Related]
9. [Clinical characteristics of hepatic flare and efficacy of antiviral therapy in pregnant women with chronic hepatitis B virus infection].
Ding Y; Sheng QJ; Zhang C; Wu YY; Yuan SY; Xia TT; An ZY; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):106-111. PubMed ID: 30818914
[No Abstract] [Full Text] [Related]
10. [Impact of cessation of antiviral therapy at delivery on postpartum liver function in mothers with chronic hepatitis B virus infection].
Guo HJ; Gao YF; Liu HY; He HT; Huang MT; Cai DC; Liao DD; Li JN; Yin XR; Liu ZH; Hu J
Zhonghua Gan Zang Bing Za Zhi; 2019 Feb; 27(2):112-117. PubMed ID: 30818915
[No Abstract] [Full Text] [Related]
11. Effect of Antiviral Therapy During Pregnancy on Natural Killer Cells in Pregnant Women With Chronic HBV Infection.
Wang F; Xie S; Ran C; Hao H; Jiang T; Deng W; Bi X; Lin Y; Yang L; Sun F; Zeng Z; Xie Y; Li M; Yi W
Front Immunol; 2022; 13():893628. PubMed ID: 35677040
[TBL] [Abstract][Full Text] [Related]
12. Is the use of Tenofovir Dipivoxil fumarate effective and safe in preventing vertical transmission in pregnant women with chronic HBV with high viral load?
Aladag H; Aladag M
Eur Rev Med Pharmacol Sci; 2023 Mar; 27(5):2091-2098. PubMed ID: 36930508
[TBL] [Abstract][Full Text] [Related]
13. Characterization of T cell immunity in chronic hepatitis B virus-infected mothers with postpartum alanine transaminase flare.
Huang M; Gao Y; Yin X; Zhang X; Hao Y; Hu J; Liu Z
BMC Infect Dis; 2021 Sep; 21(1):922. PubMed ID: 34488681
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China: An observational study.
Sheng QJ; Wang SJ; Wu YY; Dou XG; Ding Y
Medicine (Baltimore); 2018 Jun; 97(22):e10931. PubMed ID: 29851831
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.
Eke AC; Eleje GU; Eke UA; Xia Y; Liu J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD008545. PubMed ID: 28188612
[TBL] [Abstract][Full Text] [Related]
16. [Telbivudine for prevention of perinatal transmission in pregnant women infected with hepatitis B virus in immune-tolerant phase: a study of efficacy and safety of drug withdrawal].
Sheng QJ; Ding Y; Li BJ; Bai H; Zhang C; Han C; Fan YX; Li YW; Dou XG
Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):258-64. PubMed ID: 27470623
[TBL] [Abstract][Full Text] [Related]
17. The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy.
Xiao LX; Chen YR; Huang P; Mei YY; Pan CQ; Lin CS
J Med Virol; 2020 Dec; 92(12):3381-3389. PubMed ID: 32410298
[TBL] [Abstract][Full Text] [Related]
18. Risk factors related to postpartum hepatic inflammation in pregnant women with chronic hepatitis B.
Li L; Zou H; Xu M; Li S; Zhu Y; Zheng S; Duan Z; Chen Y
J Int Med Res; 2020 Nov; 48(11):300060520966439. PubMed ID: 33208011
[TBL] [Abstract][Full Text] [Related]
19. Clinical and Immunological Factors Associated with Postpartum Hepatic Flares in Immune-Tolerant Pregnant Women with Hepatitis B Virus Infection Treated with Telbivudine.
Lu J; Wang X; Zhu Y; Ma L; Zheng S; Hu Z; Chen X
Gut Liver; 2021 Nov; 15(6):887-894. PubMed ID: 34446613
[TBL] [Abstract][Full Text] [Related]
20. [Clinical study on liver function, virology, serological changes and the safety of drug withdrawal in pregnant women who are chronic HBV carriers during pregnancy and postpartum].
Wang XX; Lu JF; Wu YL; Ma LN; Jin Y; Cao ZH; Ren S; Liu YL; Zheng YY; Chen XY
Zhonghua Gan Zang Bing Za Zhi; 2019 Apr; 27(4):261-266. PubMed ID: 31082336
[No Abstract] [Full Text] [Related]
[Next] [New Search]
